Skip to main content
Year archive

Bavarian Nordic — 2023 filings

All 143 regulatory filings released by Bavarian Nordic (BAVA) in 2023, sourced directly from the official regulator.

143 Filings
2023 Period
2023 filings (143)
Filing Released Lang
Director's Dealing 2023
Director's Dealing
2023-12-13 English
Director's Dealing 2023
Director's Dealing
2023-12-13 Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing
2023-12-13 Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing
2023-12-13 English
Director's Dealing 2023
Director's Dealing
2023-11-30 English
Director's Dealing 2023
Director's Dealing
2023-11-30 Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing
2023-11-30 Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing
2023-11-30 Danish
Share Issue/Capital Change 2023
Share Issue/Capital Change
2023-11-30 Danish
Share Issue/Capital Change 2023
Share Issue/Capital Change
2023-11-30 English
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2023-11-30 Danish
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2023-11-30 English
Regulatory Filings 2023
Regulatory Filings
2023-10-25 Danish
Regulatory Filings 2023
Regulatory Filings
2023-10-25 English
Bavarian Nordic’s Mpox Vaccine Receives Recommendation from U.S. CDC Advisory Committee for Routine Use in Adults at Risk
Regulatory Filings
2023-10-25 Danish
Bavarian Nordic’s Mpox Vaccine Receives Recommendation from U.S. CDC Advisory Committee for Routine Use in Adults at Risk
Regulatory Filings
2023-10-25 English
Director's Dealing 2023
Director's Dealing
2023-09-04 English
Director's Dealing 2023
Director's Dealing
2023-09-04 Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing
2023-09-04 Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing
2023-09-04 English
Director's Dealing 2023
Director's Dealing
2023-09-01 English
Director's Dealing 2023
Director's Dealing
2023-09-01 Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing
2023-09-01 Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing
2023-09-01 English
Regulatory Filings 2023
Regulatory Filings
2023-08-31 Danish
Earnings Release 2023
Earnings Release Q3 2023
2023-08-31 Danish
Bavarian Nordic Provides Update on COVID-19 Booster Vaccine Program
Regulatory Filings
2023-08-31 Danish
Bavarian Nordic Provides Update on COVID-19 Booster Vaccine Program
Regulatory Filings
2023-08-31 English
Earnings Release 2023
Earnings Release H1 2023
2023-08-23 Danish
Earnings Release 2023
Earnings Release H1 2023
2023-08-23 English
Bavarian Nordic Announces First Half 2023 Results
Interim / Quarterly Report H1 2023
2023-08-23 English
Bavarian Nordic Announces First Half 2023 Results
Interim / Quarterly Report H1 2023
2023-08-23 English
Earnings Release 2023
Earnings Release Q3 2023
2023-08-06 Danish
Earnings Release 2023
Earnings Release FY 2023
2023-08-06 English
Bavarian Nordic Reports Positive Phase 3 Topline Results for Chikungunya Virus Vaccine in Adults and Adolescents
Regulatory Filings
2023-08-06 Danish
Bavarian Nordic Reports Positive Phase 3 Topline Results for Chikungunya Virus Vaccine in Adults and Adolescents
Regulatory Filings
2023-08-06 Danish
Earnings Release 2023
Earnings Release FY 2023
2023-08-03 Danish
Capital/Financing Update 2023
Capital/Financing Update
2023-08-03 English
Bavarian Nordic Receives USD 120 Million Contract for the Manufacturing of Smallpox and Mpox Vaccine from the U.S. Government
Regulatory Filings
2023-08-03 Danish
Bavarian Nordic Receives USD 120 Million Contract for the Manufacturing of Smallpox and Mpox Vaccine from the U.S. Government
Regulatory Filings
2023-08-03 Danish
Earnings Release 2023
Earnings Release FY 2023
2023-07-22 Danish
Earnings Release 2023
Earnings Release H1 2023
2023-07-22 English
Bavarian Nordic Provides Update on RSV Vaccine Program
Regulatory Filings
2023-07-22 Danish
Bavarian Nordic Provides Update on RSV Vaccine Program
Regulatory Filings
2023-07-22 English
Regulatory Filings 2023
Regulatory Filings
2023-06-27 Danish
Earnings Release 2023
Earnings Release Q2 2023
2023-06-27 English
Bavarian Nordic Reports Phase 3 Topline Results for its COVID-19 Booster Vaccine Candidate
Regulatory Filings
2023-06-27 Danish
Bavarian Nordic Reports Phase 3 Topline Results for its COVID-19 Booster Vaccine Candidate
Regulatory Filings
2023-06-27 English
Regulatory Filings 2023
Regulatory Filings
2023-06-23 English
Regulatory Filings 2023
Regulatory Filings
2023-06-23 Danish
Bavarian Nordic to Supply Smallpox Vaccines for EU Strategic Reserve
Regulatory Filings
2023-06-23 Danish
Bavarian Nordic to Supply Smallpox Vaccines for EU Strategic Reserve
Regulatory Filings
2023-06-23 Danish
Earnings Release 2023
Earnings Release Q2 2023
2023-06-20 English
Earnings Release 2023
Earnings Release Q2 2023
2023-06-20 Danish
Bavarian Nordic Reports Data from a Phase 3 Clinical Trial of its VLP-Based Chikungunya Virus Vaccine in Adults ≥65 Years of Age
Regulatory Filings
2023-06-20 Danish
Bavarian Nordic Reports Data from a Phase 3 Clinical Trial of its VLP-Based Chikungunya Virus Vaccine in Adults ≥65 Years of Age
Regulatory Filings
2023-06-20 English
Regulatory Filings 2023
Regulatory Filings
2023-06-16 Danish
Regulatory Filings 2023
Regulatory Filings
2023-06-16 English
Bavarian Nordic Reports 12-Month Durability Data from a Phase 2 Clinical Trial of its COVID-19 Vaccine Candidate
Regulatory Filings
2023-06-16 Danish
Bavarian Nordic Reports 12-Month Durability Data from a Phase 2 Clinical Trial of its COVID-19 Vaccine Candidate
Regulatory Filings
2023-06-16 English
Director's Dealing 2023
Director's Dealing
2023-06-12 Danish
Director's Dealing 2023
Director's Dealing
2023-06-12 English
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing
2023-06-12 Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing
2023-06-12 Danish
Director's Dealing 2023
Director's Dealing
2023-05-23 Danish
Director's Dealing 2023
Director's Dealing
2023-05-23 English
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing
2023-05-23 Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing
2023-05-23 Danish
Share Issue/Capital Change 2023
Share Issue/Capital Change
2023-05-23 Danish
Share Issue/Capital Change 2023
Share Issue/Capital Change
2023-05-23 English
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2023-05-23 Danish
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2023-05-23 Danish
Transaction in Own Shares 2023
Transaction in Own Shares
2023-05-17 English
Transaction in Own Shares 2023
Transaction in Own Shares
2023-05-17 Danish
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program
Transaction in Own Shares
2023-05-17 English
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program
Transaction in Own Shares
2023-05-17 English
M&A Activity 2023
M&A Activity
2023-05-15 Danish
M&A Activity 2023
M&A Activity
2023-05-15 English
Bavarian Nordic Completes Acquisition of Travel Vaccine Portfolio from Emergent BioSolutions
M&A Activity
2023-05-15 Danish
Bavarian Nordic Completes Acquisition of Travel Vaccine Portfolio from Emergent BioSolutions
M&A Activity
2023-05-15 Danish
Transaction in Own Shares 2023
Transaction in Own Shares
2023-05-09 Danish
Transaction in Own Shares 2023
Transaction in Own Shares
2023-05-09 English
Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations
Transaction in Own Shares
2023-05-09 Danish
Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations
Transaction in Own Shares
2023-05-09 English
Director's Dealing 2023
Director's Dealing
2023-05-01 Danish
Director's Dealing 2023
Director's Dealing
2023-05-01 English
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing
2023-05-01 Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing
2023-05-01 English
Director's Dealing 2023
Director's Dealing
2023-04-25 Danish
Director's Dealing 2023
Director's Dealing
2023-04-25 English
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing
2023-04-25 Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing
2023-04-25 English
Regulatory Filings 2023
Regulatory Filings
2023-04-11 Danish
Regulatory Filings 2023
Regulatory Filings
2023-04-11 English
Bavarian Nordic Completes Case Accrual for RSV Phase 3 Clinical Trial
Regulatory Filings
2023-04-11 Danish
Bavarian Nordic Completes Case Accrual for RSV Phase 3 Clinical Trial
Regulatory Filings
2023-04-11 English
Director's Dealing 2023
Director's Dealing
2023-03-17 Danish
Director's Dealing 2023
Director's Dealing
2023-03-17 English
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing
2023-03-17 Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing
2023-03-17 English
Share Issue/Capital Change 2023
Share Issue/Capital Change
2023-03-16 English
Share Issue/Capital Change 2023
Share Issue/Capital Change
2023-03-16 Danish
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2023-03-16 Danish
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2023-03-16 English
Director's Dealing 2023
Director's Dealing
2023-03-02 English
Remuneration Information 2023
Remuneration Information
2023-03-02 Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing
2023-03-02 Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing
2023-03-02 Danish
Annual Report 2022
Annual Report FY 2022
2023-03-02 English
Annual Report 2022
Annual Report FY 2022
2023-03-02 English
Report Publication Announcement 2023
Report Publication Announcement
2023-03-02 English
Annual Report 2022
Annual Report FY 2022
2023-03-02 English
Bavarian Nordic Publishes Annual Report 2022
Report Publication Announcement
2023-03-02 Danish
Bavarian Nordic Publishes Annual Report 2022
Report Publication Announcement
2023-03-02 Danish
Bavarian Nordic Publishes Annual Report 2022
Report Publication Announcement
2023-03-02 English
Share Issue/Capital Change 2023
Share Issue/Capital Change
2023-02-23 English
Share Issue/Capital Change 2023
Share Issue/Capital Change
2023-02-23 Danish
Bavarian Nordic A/S - Registration of Share Capital Increase of 7,046,839 New Shares Completed
Share Issue/Capital Change
2023-02-23 Danish
Bavarian Nordic A/S - Registration of Share Capital Increase of 7,046,839 New Shares Completed
Share Issue/Capital Change
2023-02-23 Danish
Capital/Financing Update 2023
Capital/Financing Update
2023-02-20 Danish
Capital/Financing Update 2023
Capital/Financing Update
2023-02-20 English
Bavarian Nordic A/S Announces Completion of Directed Issue of 7,046,839 New Ordinary Shares
Share Issue/Capital Change
2023-02-20 Danish
Bavarian Nordic A/S Announces Completion of Directed Issue of 7,046,839 New Ordinary Shares
Share Issue/Capital Change
2023-02-20 Danish
Capital/Financing Update 2023
Capital/Financing Update
2023-02-20 English
Share Issue/Capital Change 2023
Share Issue/Capital Change
2023-02-20 Danish
Bavarian Nordic A/S Launches Offering of up to 7,046,839 New Shares in a Directed Issue
Share Issue/Capital Change
2023-02-20 Danish
Bavarian Nordic A/S Launches Offering of up to 7,046,839 New Shares in a Directed Issue
Share Issue/Capital Change
2023-02-20 Danish
Director's Dealing 2023
Director's Dealing
2023-02-20 English
Director's Dealing 2023
Director's Dealing
2023-02-20 Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing
2023-02-20 Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing
2023-02-20 English
M&A Activity 2023
M&A Activity
2023-02-15 Danish
M&A Activity 2023
M&A Activity
2023-02-15 English
Bavarian Nordic to Acquire Portfolio of Travel Vaccines from Emergent BioSolutions
M&A Activity
2023-02-15 Danish
Bavarian Nordic to Acquire Portfolio of Travel Vaccines from Emergent BioSolutions
M&A Activity
2023-02-15 English
Regulatory Filings 2023
Regulatory Filings
2023-02-15 Danish
Earnings Release 2023
Earnings Release FY 2023
2023-02-15 English
Bavarian Nordic Provides Pipeline Update and Financial Guidance for 2023
Earnings Release FY 2023
2023-02-15 Danish
Bavarian Nordic Provides Pipeline Update and Financial Guidance for 2023
Earnings Release FY 2023
2023-02-15 English
Earnings Release 2022
Earnings Release FY 2022
2023-01-16 English
Earnings Release 2022
Earnings Release FY 2022
2023-01-16 Danish
Bavarian Nordic Reports Better Than Expected Preliminary Financial Results for 2022
Earnings Release FY 2022
2023-01-16 Danish
Bavarian Nordic Reports Better Than Expected Preliminary Financial Results for 2022
Earnings Release FY 2022
2023-01-16 English